Zobrazeno 1 - 10
of 16
pro vyhledávání: '"S V Yarmoschuk"'
Autor:
O E Bryzgunova, I A Zaporozhchenko, E A Lekchnov, E V Amelina, M Yu Konoshenko, S V Yarmoschuk, O A Pashkovskaya, A A Zheravin, S V Pak, E Yu Rykova, P P Laktionov
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0215003 (2019)
Urine of prostate cancer (PCa) carries miRNAs originated from prostate cancer cells as a part of both nucleoprotein complexes and cell-secreted extracellular vesicles. The analysis of such miRNA-markers in urine can be a convenient option for PCa scr
Externí odkaz:
https://doaj.org/article/4e9c83314e5a4e4895770d4ee257331a
Autor:
Pavel P. Laktionov, Evgeniy A. Lekchnov, Maria Yu. Konoshenko, S. V. Yarmoschuk, Svetlana V. Pak, Olga E. Bryzgunova, E. V. Amelina
Publikováno v:
Diagnostics
Volume 10
Issue 8
Diagnostics, Vol 10, Iss 600, p 600 (2020)
Volume 10
Issue 8
Diagnostics, Vol 10, Iss 600, p 600 (2020)
MiRNAs of blood and urine have been shown to represent a convenient source of biomarkers for prostate cancer (PCa) diagnosis and assessment of the therapy effectiveness due to their high stability and representation and the low invasiveness of sample
Autor:
S. V. Yarmoschuk, Svetlana V. Pak, Olga E. Bryzgunova, Ivan A. Zaporozhchenko, O. A. Pashkovskaya, P. P. Laktionov, Maria Yu. Konoshenko, Evgeniy A. Lekchnov
Publikováno v:
Diagnostics, Vol 10, Iss 1, p 38 (2020)
Diagnostics
Volume 10
Issue 1
Diagnostics
Volume 10
Issue 1
Prostate cancer is a global biological, medical, and social issue aggravated by the lack of reliable, highly specific, and sensitive non-invasive tests for diagnosis and staging of prostate cancer. One prospective source of biomarkers are the cell-fr
Autor:
E. Yu. Rykova, Yu. B. Yurchenko, Ivan D. Osipov, Olga E. Bryzgunova, O. A. Pashkovskaya, Pavel P. Laktionov, M. M. Zaripov, Ivan A. Zaporozhchenko, S. V. Yarmoschuk, A. A. Zheravin, E. A. Lekchnov
Publikováno v:
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry. 12:156-163
Urine of prostate cancer patients contains tumor-specific biopolymers, including protein- and microvesicles-associated miRNAs that can potentially be used as oncomarkers. Previously we have characterized urinary extracellular vesicles and demonstrate
Autor:
A. A. Zheravin, Yu. B. Yurchenko, E. Yu. Rykova, M. M. Zaripov, O. E. Bryzgunova, S. V. Yarmoschuk, O. A. Pashkovskaya, E. A. Lekchnov, P. P. Laktionov
Publikováno v:
AIP Conference Proceedings.
Presence of tumor-derived cell-free miRNA in biological fluids as well as simplicity and robustness of cell-free miRNA quantification makes them suitable markers for cancer diagnostics. Based on previously published data demonstrating diagnostic pote
Autor:
E. A. Lekchnov, A. A. Zheravin, Pavel P. Laktionov, S. V. Yarmoschuk, O. E. Bryzgunova, O. A. Pashkovskaya, E. V. Amelina, M.Y. Konoshenko, Ivan A. Zaporozhchenko, Elena Y. Rykova
Publikováno v:
Annals of Oncology. 30:v22
Background Prostate cancer (PCa) is one of the major cancers in men, but discrepancy between incidence and mortality calls for a careful approach to screening and diagnosis. Controversy between US Preventive Services Task Force recommendations and th
Autor:
M. Yu. Konoshenko, S. V. Yarmoschuk, O. A. Pashkovskaya, E. A. Lekchnov, A. A. Zheravin, E. V. Amelina, Ivan A. Zaporozhchenko, Pavel P. Laktionov, Svetlana V. Pak, E. Yu. Rykova, O. E. Bryzgunova
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0215003 (2019)
Urine of prostate cancer (PCa) carries miRNAs originated from prostate cancer cells as a part of both nucleoprotein complexes and cell-secreted extracellular vesicles. The analysis of such miRNA-markers in urine can be a convenient option for PCa scr
Autor:
S. V. Yarmoschuk, E. A. Drobyazgin, Yu. V. Chikinev, A. A. Zheravin, A. S. Kudryavtsev, I. E. Sudovykh
Publikováno v:
Endoskopicheskaya khirurgiya. 24:45
Publikováno v:
Endoskopicheskaya khirurgiya. 23:26
Autor:
E. A. Drobyazgin, A. N. Arkhipov, Yu. V. Chikinev, A. S. Kudryavtsev, S. V. Yarmoschuk, A. A. Zheravin
Publikováno v:
Endoskopicheskaya khirurgiya. 23:13